Table 1 Demographic characteristics of gout patients (N = 177,637)
From: Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population
N | % | |
|---|---|---|
Male gender | 134,333 | 75.6% |
Age in categories | ||
20-49 | 59,371 | 33.4% |
50-59 | 54,612 | 30.7% |
60-69 | 37,016 | 20.8% |
70-79 | 19,790 | 11.1% |
80-89 | 6,848 | 3.9% |
Comorbidities: | ||
Cardiometabolic | 91,203 | 51.3% |
Congestive Heart Failure | 7,467 | 4.2% |
Ischemic Heart Disease | 18,066 | 10.2% |
Hypertension | 64,094 | 36.1% |
Conduction and rhythm disorder | 12,034 | 6.8% |
Cerebrovascular disease | 4,934 | 2.8% |
Peripheral arterial disease | 6,271 | 3.5% |
Chronic renal impairment | 5,718 | 3.2% |
Dyslipidemia | 47,960 | 27.0% |
Diabetes | 26,818 | 15.1% |
Gastrointestinal | 14,224 | 8.0% |
Gastrointestinal | 11,836 | 6.7% |
Hepatic disorders | 2,718 | 1.5% |
Pancreatic disorders | 501 | 0.3% |
Haematological (Anemia) | 3,829 | 2.2% |
Myopathy | 159 | 0.1% |
Arthritis | 25,516 | 14.4% |
Osteoporosis | 5,044 | 2.8% |
Any comorbidity | 103,281 | 58.1% |
Gout diagnosis recorded by: | ||
Primary care physician | 56,512 | 31.8% |
Rheumatologist | 4,731 | 2.7% |
Emergency visit | 10,482 | 5.9% |
Other or Unknown specialty | 105,912 | 59.6% |
Hospitalized in 12 months follow-up (at least once) | 2,119 | 1.2% |
Outpatient visit in 12 months follow-up (at least once) | 65,665 | 37.0% |
Number of flares in 12 months follow-up: | ||
0 | 158,268 | 89.1% |
1 | 15,893 | 9.0% |
2 | 2,790 | 1.6% |
3 or more | 686 | 0.4% |